There were a lot of bummed out investors when VANC Pharmaceuticals rolled back their share base recently, but the dip has brought about a very interesting last 48 hours…
Pharmaceuticals
So how do you want to handle the next few years of political madness and megalomania? War might be around the corner, revolution not far behind, and they may…
Prepare for the next great Canadian marijuana wave. Going against popular wisdom (and, admittedly, what I’ve been saying for a year now could never happen), the Canadian weed taskforce…
I guessed Emblem would drop at around $200m and wasn’t far off, but what’s been most impressive about the next big marijuana deal’s drop into the Venture Exchange wasn’t…
Emblem Cannabis (EMC.V) hasn’t had to be loud about it. The Canadian investor base has been calling and pleading and goading and pushing to get in on its pre-listing…
Typical. Not one to let an opportunity pass by without grabbing another damn asset, Marc Lustig at CannaRoyalty (formerly Cannabis Royalties) today announced his company’s debut on the CSE…
I love it when I get to use the phrase ‘company maker’, but it doesn’t happen so often. Today, Canabo Medical (CMM.V) got to pull out the company maker…
A year back, I was hitting the medical marijuana sector pretty hard in terms of coverage, writing regularly about everyone from the giants in the making to the companies…
In the spirit of ‘where are they now’ day comes another in my trilogy of companies I used to write about a lot, that I stopped writing about as…
Biotech flailer Hemostemix (HEM.V) took a punch to its distended gut today as a sell-off of the embattled stock cut the share price of the company by nearly half,…